Gland Pharma Profit

2026-08-10

India's Gland Pharma beats quarterly profit view on strong Europe, US sales

India's Gland Pharma beat quarterly profit estimates with a $33.3 million net profit, driven by 32% U.S. and 20% European sales growth. Recovery at its Cenexi production units in France and Belgium su

reuters · 2026-08-10 04:08 UTC

2026-06-11

Reliance, Vedanta, Adani Join India's Drive to Cut China Rare Earth Dependence, Sources Say

Indian industrial groups Reliance, Vedanta, and Adani plan to develop rare earth processing facilities in Andhra Pradesh to reduce China dependence, backed by government incentives and significant min

reuters · 2026-06-11 02:34 UTC

2026-05-17

Indian Shares Join Asian Slump as US-Iran Stalemate Continues

Indian stocks and the rupee declined as Middle East tensions pushed Brent crude to $112 per barrel. While Reliance and Tata Steel fell, Gland Pharma surged on strong quarterly profits.

reuters · 2026-05-17 19:41 UTC

Media coverage (3)

India's Gland Pharma beats quarterly profit view on strong Europe, US salesreuters
Reliance, Vedanta, Adani Join India's Drive to Cut China Rare Earth Dependence, Sources Sayreuters
Indian Shares Join Asian Slump as US-Iran Stalemate Continuesreuters

Gland Pharma Profit

India's Gland Pharma beats quarterly profit view on strong Europe, US sales

Reliance, Vedanta, Adani Join India's Drive to Cut China Rare Earth Dependence, Sources Say

Indian Shares Join Asian Slump as US-Iran Stalemate Continues

Media coverage (3)

Related topics